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Caso Clínico
Clinical Case
Resumo
Apesar da ampla cobertura vacinal, a infecção por Bor-
detella pertussis está longe de estar controlada. Os 
recém -nascidos e lactentes ainda sem imunização com-
pleta e filhos de mães com baixos títulos de anticorpos 
para a Bordetella pertussis são altamente susceptíveis à 
infecção e têm maior risco de doença grave e morte. A 
infecção por Bordetella pertussis associada a hipertensão 
pulmonar no recém -nascido é frequentemente fatal. 
Abstract
In spite of the availability and widespread use of vac-
cines, pertussis is far from controlled. Newborns and 
infants too young to be fully vaccinated, born from 
mothers with low antibody titers to Bordetella pertus-
sis, are highly susceptible to infection and at risk of 
severe disease and death. Pertussis associated with 
pulmonary hypertension in the newborn is often fa-
tal. The authors report a clinical case of severe 
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Os autores descrevem um caso clínico de doença grave 
num recém -nascido com insuficiência respiratória agu-
da e hipertensão pulmonar grave, tratado com sucesso 
com sildenafil e óxido nítrico inalado.
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pertussis -induced respiratory failure associated to se-
vere pulmonary hypertension in a neonate success-
fully treated with sildenafil and inhaled nitric oxide.
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Introduction
In spite of the availability and widespread use 
of vaccines, pertussis is far from controlled1-3. 
Newborns and infants too young to be fully 
vaccinated are highly susceptible to infection 
and are at high risk of severe disease and 
death1,4,5. Infants with pertussis may indicate 
undetected source cases in the community6.
Clinical presentation of pertussis in the newborn 
may lack some features typical of the disease in 
older children1. The characteristic “whoop” and 
fever may be absent1. The clinical picture of the 
most severely affected newborns may be domi-
nated by marked respiratory distress, cyanosis, 
and apnea1. Pertussis associated with pulmonary 
hypertension in the newborn is often irreversible 
and associated to a poor outcome2,6-8.
The authors report a clinical case of severe 
pertussis-induced respiratory failure associa-
ted to severe pulmonary hypertension in a 
neonate with good outcome.
Case report
A 6 day-old white male infant born at term 
by caesarean section to a healthy, 38 year-
old, gravida II, para 0 mother, following a 
normal pregnancy, developed cyanotic epi-
sodes with no other associated symptoms at 
presentation. The mother denied infectious 
exposures.
He was admitted to the neonatal intensive 
care unit (NICU). He was afebrile, tachyp-
neic, and presented labial cyanosis with cry-
ing. The resting transcutaneous oxygen sat-
uration was 98%. The white blood cell 
count was 9.9×109/L (62% lymphocytes) 
and the reactive C protein was 0.72 mg/dl. 
The chest X-ray revealed diffuse bilateral 
pulmonary infiltrates (figure1). The echocar-
diographic evaluation revealed a structurally 
normal heart and severe pulmonary hyper-
tension. Intravenous ampicillin and gen-
tamicin were initiated.
Three hours after NICU admission he de-
veloped severe respiratory distress with pro-
gressive respiratory failure, requiring trache-
al intubation and respiratory support with 
increasing ventilation parameters [maximal 
peak inspiratory pressure (PIP) 30 cmH2O, 
rate 70/min, and FiO2 = 1]. The oxygen-
ation index was > 20 (OI = mean airway 
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pressure × FiO2 × 100 / PaO2). There was no 
improvement in pulmonary status after a 
trial of exogenous surfactant. Inhaled nitric 
oxide (iNO 20 ppm) was initiated 40 hours 
after admission.
At day three, inotropic support with dopa-
mine was required. The pulmonary hyper-
tension remained severe (estimated pulmo-
nary artery pressure > 100 mmHg) and 
treatment with sildenafil was initiated (0.25 
mg/kg in the first day, followed by 0.25 mg/
kg/ day increments until a total dose of 2 
mg/kg, via orogastric tube).
At day six, estimated pulmonary artery pres-
sure was about 70 mmHg, oxygenation in-
dex was below 20, and weaning of iNO was 
started with a decrease of 2 ppm every four 
hours. iNO was used for a total of five days. 
From day two to day three iNo was used in 
association to increasing doses of sildenafil.
Blood cultures were negative as were rapid 
diagnostic testing for respiratory virus in 
nasopharyngeal aspirate. The initial work-
up included a nasopharyngeal wash fluid 
culture and polymerase chain reaction 
(PCR) for Bordetella pertussis (Properetussis 
Real Time-Prodesse, Waukesha, WI, USA). 
The PCR was positive so the patient started 
a full course of erythromycin. Antibody ti-
ters to Bordetella pertussis were not elevated. 
The family evaluation revealed that a three 
years old brother presented a flu-like syn-
drome with mild cough during the previous 
days, but no further cases of respiratory in-
fection were disclosed in close relatives. All 
family members were treated with erythro-
mycin. Laboratory evaluation of the brother 
was not performed.
The child’s pulmonary vascular pressures 
and respiratory status improved gradually 
over the next days. Sildenafil was weaned 
from day 17 to day 24. He was extubated 
18 days after NICU admission, and dis-
charged six days latter.
At six months of age the child is asymptom-
atic and presents a good development.
Discussion
Pertussis is a highly contagious respiratory 
bacterial infection caused by Bordetella per-
tussis, a Gram-negative bacillus4. In spite of 
widespread immunization, pertussis occurs 
in exposed and unprotected newborns 1-3 
and remains one of the most common 
causes of death from infectious diseases 
worldwide3,4. Older children or adults in 
the household with undiagnosed mild di-
sease are the usual sources of infection for 
neonates1,3,9,10. In 1997, almost 24% of the 
notified cases in the United States occurred 
Fig. 1 – The chest X-ray at admission revealed diffuse 
pulmonary infi ltrates predominant in the upper 2/3 of both 
pulmonary fi elds
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in infants less than six months age, inclu-
ding 18% in less than three months10,11. Ac-
cording to a study by Wendelboe AM et al, 
household members are responsible for 
76% – 83% of transmission of Bordetella 
petussis to infants12. Pertussis in infants less 
than one year of age should be considered as 
an indicator of undetected disease in the 
community6.
Mortality due to pertussis usually results 
from secondary pneumonia, encephalopa-
thy, cardiac failure, or pulmonary hyper-
tension1,7. Most deaths occur among un-
vaccinated children or children too young 
to be vaccinated5. Patients younger than six 
weeks present the highest mortality4. Al-
most all cases of pertussis in the neonate 
associated with pulmonary hypertension 
reported in the international literature were 
fatal2,6-8.
Antibody to Bordetella pertussis crosses the 
placenta and titers in immune mothers and 
their newborns are approximately equal1. 
High titers of passively transferred antibody 
are protective for the newborn1. Many 
women vaccinated during infancy present 
low serum levels of antibody when they 
reach childbearing age. These levels of anti-
body may be insufficient to protect the off-
spring, if they are exposed to pertussis du-
ring the first few months of life1. We did not 
evaluate the mother’s titers of antibody, but 
we believe that they were insufficient for the 
newborn`s protection.
No serological test (IgG and IgA) is diag-
nostic for Bordetella pertussis infection in 
spite of the widespread and heterogeneous 
stimulated immunological response, diffe-
ring between individuals according to age 
and previous exposure to microorganism or 
vaccine10. Our patient was in an unimmu-
nized and immunocompromised state as 
result of his age, and this may be the expla-
nation for the low titers of antibodies.
Although not specific, elevation of white 
blood cells and lymphocytosis are common 
findings in the classic Bordetella pertussis 
infection10.
When newborns or infants present with un-
explained pulmonary hypertension and re-
spiratory failure, the diagnosis of pertussis 
should be investigated4. The standard ap-
proach to the diagnosis of pertussis include 
a nasopharyngeal wash culture, direct fluo-
rescent antibody, serology and polymerase 
chain reaction1,4. It is helpful to inform the 
laboratory of the suspicion because a spe-
cialized agar medium (Regan-Lowe or Bor-
det-Gengou) is required1. This may be the 
reason why the cultures performed were 
negative in this case report. Anyway, with 
special culture mediums the incubation pe-
riod lasts about 10-14 days.
PCR for Bordetella pertussis is a useful tool 
for pertussis diagnosis, particularly in pre-
vacinated infants13,14. The new molecular 
assay proved to be suitable for the rapid 
 diagnosis of pertussis in the routine diag-
nostic laboratory15-18. PCR positive results 
may be obtained at least 21 days after the 
onset of clinical symptoms19. PCR was the 
only positive marker of infection in this case 
report. Whether one single positive value of 
PCR is enough for the diagnosis is a ques-
tion that, in this particular case, could only 
be answered by the apparent response to 
treatment with erythromycin.
iNO is a selective pulmonary vasodilator 
without significant effects on the systemic 
circulation. It causes vasodilation by acting 
on the receptors in the muscle wall of the 
blood vessels. Guanylyl cyclase activation 
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leads to production of cyclic guanosine 
monophosphate (GMP) and subsequent 
smooth muscle relaxation, the same mecha-
nism of endogenous NO. Excess iNO is 
quickly bound to and inactivated, produc-
ing methemoglobin. The half-life is less 
than five seconds, and it is usually given 
continuously as a gas by inhalation. Sildena-
fil is selective phosphodiesterase (PDE5) 
inhibitor. This inhibition leads to accumu-
lation of cyclic GMP in pulmonary smooth 
muscle cells, causing pulmonary vascular 
relaxation, and it may potentiate the effect 
of iNO. The association of sildenafil may 
also help on the gradual weaning of iNO. 
Data on sildenafil use in neonates are very 
limited. The most concerning short term 
adverse effects are worsening oxygenation 
and systemic hypotension, occurring main-
ly in patients with sepsis. A case of severe 
retinopathy of prematurity has also been 
described20.
The early echocardiographic evaluation 
was important for the diagnosis of pulmo-
nary hypertension. The prompt treatment 
with iNO and the association of sildenafil 
were successful in this case, and up to our 
know ledge were never reported in the li-
terature in similar situations. Our case 
supports the idea that the immediate 
diagnosis and treatment of pulmonary 
hypertension in the course of the pertussis 
disease are import measures for the suc-
cess of treatment.
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